PTX-9908

N/A

Report date: 2023/12/08 13:50:15
NME

Base Information

Drug NamePTX-9908
Drug Alias NamePTX-9908
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulatorsC-X-C motif chemokine ligand 12 antagonists
TargetsC-X-C motif chemokine receptor 4C-X-C motif chemokine ligand 12
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPertinax Therapeutics
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesMicroconstants China IncTcm Biotech International Corp
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A